Pro Tip: Learn how to use HBI Alerts to follow your favorite topics

Radiotherapy

 

PWC on M&A drivers in Spanish healthcare sector

The Spanish private healthcare market has been one of Europe's most attractive for institutional investors of late with strong organic and inorganic growth opportunities. PWC Spain's deals leader for Healthcare & Pharma Jose Zarzalejos talks us through the drivers, movers and shakers in the six main sub-sectors: hospitals, imaging, oncology, care homes, IVF and dentistry.
September 24, 2020

Medipass sells to infra minus its healthcare services

Gruppo KOS has sold managed equipment services provider Medipass to Deutsche Bank's asset management arm DWS, which closed a €2.5bn infrastructure fund last year. The deal will see KOS keep Medipass' only healthcare services assets - its Indian subsidiaries - although a source says it will look to sell those swiftly.
September 10, 2020

Unilabs’ TMC muscling in on UK teleradiology market

Unilabs' teleradiology arm European Telemedicine Clinic (TMC) has launched a specialised oncology offering in the UK where it now has a 20% market share, its country head tells HBI. He adds that COVID-19 has seen NHS radiology departments clear routine imaging reporting lists for the first time in 20 years, although outsourcing is picking up again.
June 11, 2020

CVC bumps up offer price for HCG

PE firm CVC has increased its offer for Indian oncology chain HCG in anticipation of a rival bid from another of the cancer chain's large shareholders, Temasek. 
June 11, 2020

How cancer care is changing across Europe

Oncology patients are among the most vulnerable in the current pandemic. Will that lead to more outmigration of therapies and increased use of hypofractionation? HBI speaks to operators in the France, Germany and the UK. 
June 9, 2020

Covid: The double whammy – who will be left standing?

In a recent paper on the medtech outlook for Europe, UBS, looked at how Singapore and Toronto bounced back from pandemics. Pent up demand simply led to double growth rates the year after. But Covid is two things: a pandemic coupled to a steep recession, almost certainly worse than 2008. We look at what this means for a sector where private equity has often geared up to the hilt.
April 16, 2020

Amethyst moves into UK market

Pan-European radiotherapy group Amethyst has moved into the UK market by buying the company behind two Gamma Knife centres. 
April 9, 2020

‘There is no deal for private sector to take UK NHS cancer patients’

Cancer companies in the UK do not have a contract with the NHS to take 20,000 public patients, despite an earlier report to the contrary in a UK broadsheet newspaper. Providers tell HBI that they fear that a mass of 'second-wave deaths' and look at how pressure might transform clinical pathways in oncology.
April 9, 2020
Older posts
Newer posts

Our Services

Company

Resources

Log in
Register
Log in
Register

Our Services

Company

Resources

Find Us